Efficacy and safetyof an anti-CD20monoclonal antibody(Reditux™) for thetreatment of patientswith moderate tosevere rheumatoidarthritis followingthe… Manjeet BhatiSoham Bandyopadhyay2016 год

Efficacy and safety of an anti-CD20 monoclonal antibody (Reditux™) for the treatment of patients with moderate to severe rheumatoid arthritis following the failure of conventional synthetic disease-modifying anti-rheumatic drugs
статья из журнала